Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been recognized as potent antioxidant agents. Since SGLT2i are nephroprotective drugs, we aimed to examine the urine antioxidant status in patients with type 2 diabetes mellitus (T2DM). One hundred and one subjects participated in this study, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabrdalik-Leśniak, Diana, Nabrdalik, Katarzyna, Sedlaczek, Katarzyna, Główczyński, Patryk, Kwiendacz, Hanna, Sawczyn, Tomasz, Hajzler, Weronika, Drożdż, Karolina, Hendel, Mirela, Irlik, Krzysztof, Stelmach, Paweł, Adamczyk, Piotr, Paradysz, Andrzej, Kasperczyk, Sławomir, Stompór, Tomasz, Gumprecht, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294983/
https://www.ncbi.nlm.nih.gov/pubmed/34336104
http://dx.doi.org/10.1155/2021/5593589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294983/
https://www.ncbi.nlm.nih.gov/pubmed/34336104
http://dx.doi.org/10.1155/2021/5593589

Ejemplares similares